A 28-year-old woman is brought to the emergency department 2 hours after ingesting an unknown quantity of organophosphate pesticide. She presents with pinpoint pupils, excessive salivation, muscle fasciculations, and respiratory distress. Regarding the management of organophosphate poisoning, all of the following statements are true EXCEPT:

Explanation

## Organophosphate Poisoning Management ### Mechanism of Toxicity Organophosphates irreversibly inhibit acetylcholinesterase, leading to accumulation of acetylcholine and overstimulation of both muscarinic and nicotinic receptors. ### Correct Management Principles | Agent | Role | Mechanism | |-------|------|----------| | **Atropine** | First-line antidote | Blocks muscarinic receptors; reverses salivation, bronchospasm, bradycardia | | **Pralidoxime (2-PAM)** | Oxime reactivator | Removes phosphoryl group from AChE if given early (within 24–48 hours) | | **Benzodiazepines** | Adjunctive | Control seizures and fasciculations | | **Physostigmine** | Contraindicated | Further inhibits AChE; worsens cholinergic crisis | **Key Point:** Physostigmine is an anticholinesterase and is absolutely contraindicated in organophosphate poisoning. It would deepen the cholinergic crisis by further blocking acetylcholinesterase activity. **High-Yield:** The mnemonic for organophosphate toxidrome is **SLUDGE** (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis) — all muscarinic effects reversed by atropine. **Clinical Pearl:** Pralidoxime is most effective when given within the first 24–48 hours; after this window, the phosphoryl-enzyme bond becomes "aged" and cannot be reactivated. ### Why Physostigmine Is Wrong Physostigmine is a tertiary amine anticholinesterase used for anticholinergic toxicity (e.g., atropine overdose), NOT cholinergic excess. In organophosphate poisoning, it would exacerbate the crisis [cite:KD Tripathi 8e Ch 32].